Pay in 4 interest-free payments of $5.14 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
Open (2019)
In Trial 8, one of the CV outcomes trials, 891 (56%) RYBELSUS-treated patients were 65 years of age and over and 200 (13%) RYBELSUS-treated patients were 75 years of age and over
Step 1: Assess Your Eligibility (5 Minutes) Quick Self-Check: BMI 30 or BMI 27 with health condition Age 18+ (or 12+ with parent/guardian) No thyroid cancer history (personal or family) Not pregnant or planning pregnancy soon Comfortable with weekly self-injections Can afford $199-$349/month long-term Have internet access for telehealth If you checked all boxes, you likely qualify
Abstract Background Oral semaglutide is a novel tablet containing the human glucagon-like peptide-1 (GLP1) analogue semaglutide, co-formulated with the absorption enhancer sodium N -(8-[2-hydroxybenzoyl] amino) caprylate (SNAC)
Stay Hydrated Drink plenty of water in the days leading up to your treatment
